These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The dynamic structure of jadomycin B and the amino acid incorporation step of its biosynthesis. Rix U; Zheng J; Remsing Rix LL; Greenwell L; Yang K; Rohr J J Am Chem Soc; 2004 Apr; 126(14):4496-7. PubMed ID: 15070349 [TBL] [Abstract][Full Text] [Related]
6. Mutation P732L in human DNA topoisomerase IIbeta abolishes DNA cleavage in the presence of calcium and confers drug resistance. Leontiou C; Lakey JH; Lightowlers R; Turnbull RM; Austin CA Mol Pharmacol; 2006 Jan; 69(1):130-9. PubMed ID: 16239602 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of ferrocene derivatives on the catalytic activity of topoisomerase IIalpha and beta--distinct mode of action of two derivatives. Sai Krishna AD; Panda G; Kondapi AK Arch Biochem Biophys; 2005 Jun; 438(2):206-16. PubMed ID: 15907782 [TBL] [Abstract][Full Text] [Related]
9. Novel jadomycins: incorporation of non-natural and natural amino acids. Jakeman DL; Farrell S; Young W; Doucet RJ; Timmons SC Bioorg Med Chem Lett; 2005 Mar; 15(5):1447-9. PubMed ID: 15713404 [TBL] [Abstract][Full Text] [Related]
10. Novel and expanded jadomycins incorporating non-proteogenic amino acids. Jakeman DL; Graham CL; Reid TR Bioorg Med Chem Lett; 2005 Dec; 15(23):5280-3. PubMed ID: 16185863 [TBL] [Abstract][Full Text] [Related]
11. A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation. Shapiro AB; Austin CA Anal Biochem; 2014 Mar; 448():23-9. PubMed ID: 24309019 [TBL] [Abstract][Full Text] [Related]
12. Biosynthesis, synthetic studies, and biological activities of the jadomycin alkaloids and related analogues. de Koning CB; Ngwira KJ; Rousseau AL Alkaloids Chem Biol; 2020; 84():125-199. PubMed ID: 32416952 [TBL] [Abstract][Full Text] [Related]
13. C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo. Linka RM; Porter AC; Volkov A; Mielke C; Boege F; Christensen MO Nucleic Acids Res; 2007; 35(11):3810-22. PubMed ID: 17526531 [TBL] [Abstract][Full Text] [Related]
14. Isolation of a jadomycin incorporating L-ornithine, analysis of antimicrobial activity and jadomycin reactive oxygen species (ROS) generation in MDA-MB-231 breast cancer cells. Forget SM; Robertson AW; Hall SR; MacLeod JM; Overy DP; Kerr RG; Goralski KB; Jakeman DL J Antibiot (Tokyo); 2018 Aug; 71(8):722-730. PubMed ID: 29700425 [TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta. Marchion DC; Bicaku E; Turner JG; Daud AI; Sullivan DM; Munster PN Clin Cancer Res; 2005 Dec; 11(23):8467-75. PubMed ID: 16322310 [TBL] [Abstract][Full Text] [Related]
16. Jadomycins: A potential chemotherapy for multi-drug resistant metastatic breast cancer. Bonitto EP; McKeown BT; Goralski KB Pharmacol Res Perspect; 2021 Dec; 9(6):e00886. PubMed ID: 34708587 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of friedelan triterpenoid analogs with DNA topoisomerase IIα inhibitory activity and their molecular docking studies. Mandal A; Ghosh S; Bothra AK; Nanda AK; Ghosh P Eur J Med Chem; 2012 Aug; 54():137-43. PubMed ID: 22633831 [TBL] [Abstract][Full Text] [Related]
20. Topoisomerase IIα, rather than IIβ, is a promising target in development of anti-cancer drugs. Chen W; Qiu J; Shen YM Drug Discov Ther; 2012 Oct; 6(5):230-7. PubMed ID: 23229142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]